LEVI BACHLER: Open Payments
NPI 1134199227 · SARATOGA SPRINGS, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 23 payments from 10 companies in 2025. Trend: 2023 $631 · 2024 $591 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $227 |
| Lilly USA, LLC | 2 | $40 |
| Novo Nordisk Inc | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, QULIPTA, Ozempic, Qelbree, Dyanavel XR, CAPLYTA.
Industry payments across UT — which companies pay providers there.
